Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic merkel cell carcinoma a preplanned interim analysis of a clinical trial

Sandra P. D'Angelo^*, Jeffery Russell, Céleste Lebbé, Bartosz Chmielowski, Thilo Gambichler, Jean Jacques Grob, Felix Kiecker, Guilherme Rabinowits, Patrick Terheyden, Isabella Zwiener, Marcis Bajars, Meliessa Hennessy, Howard L. Kaufman